In addition to providing the highest level of care for patients with inflammatory bowel disease, our physicians are actively involved in basic, clinical and translational research. Our diverse research projects include clinical studies of new treatments, laboratory studies of the underlying mechanisms of IBD and long-term observational studies. Some of our current studies focus on:
- Safety and efficacy of new treatments for IBD
- Adherence and outcomes in IBD management
- Genetic research, including studies of families who have multiple generations affected by Crohn's disease and/or ulcerative colitis
- Ethics and feasibility of fecal microbiota transplantation (FMT)
- The relationship between growth and inflammatory bowel disease
The goal of our research is to help identify the cause(s) of inflammatory bowel disease in order to develop more effective treatments and, ultimately, to find a cure. Through our collaborative studies, we work to discover new mechanisms that cause IBD, as well as evaluate drugs that will lead to expansion of the therapeutic options for children and adolescents young adults. Many of our patients participate in our research studies, which include clinical trials of new treatments for Crohn's disease and ulcerative colitis.